- Home
- ELWS vs CODX Comparison
ELWS vs CODX Comparison
Compare ELWS & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- CODX
- Stock Information
- Founded
- ELWS 2018
- CODX 2013
- Country
- ELWS Japan
- CODX United States
- Employees
- ELWS N/A
- CODX N/A
- Industry
- ELWS
- CODX Medical/Dental Instruments
- Sector
- ELWS
- CODX Health Care
- Exchange
- ELWS Nasdaq
- CODX Nasdaq
- Market Cap
- ELWS 12.1M
- CODX 9.8M
- IPO Year
- ELWS 2023
- CODX 2017
- Fundamental
- Price
- ELWS $2.29
- CODX $0.43
- Analyst Decision
- ELWS
- CODX Buy
- Analyst Count
- ELWS 0
- CODX 2
- Target Price
- ELWS N/A
- CODX $5.50
- AVG Volume (30 Days)
- ELWS 71.7K
- CODX 13.6M
- Earning Date
- ELWS 09-30-2025
- CODX 11-06-2025
- Dividend Yield
- ELWS N/A
- CODX N/A
- EPS Growth
- ELWS N/A
- CODX N/A
- EPS
- ELWS N/A
- CODX N/A
- Revenue
- ELWS $3,083,071.00
- CODX $1,003,653.00
- Revenue This Year
- ELWS N/A
- CODX N/A
- Revenue Next Year
- ELWS N/A
- CODX $31.58
- P/E Ratio
- ELWS N/A
- CODX N/A
- Revenue Growth
- ELWS 145.52
- CODX N/A
- 52 Week Low
- ELWS $1.64
- CODX $0.23
- 52 Week High
- ELWS $10.50
- CODX $1.40
- Technical
- Relative Strength Index (RSI)
- ELWS 43.50
- CODX 57.22
- Support Level
- ELWS $2.14
- CODX $0.30
- Resistance Level
- ELWS $2.47
- CODX $0.72
- Average True Range (ATR)
- ELWS 0.21
- CODX 0.06
- MACD
- ELWS 0.04
- CODX 0.01
- Stochastic Oscillator
- ELWS 61.05
- CODX 29.62
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.